Abbott (ABT)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-04-24 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ABBOTT LABORATORIES (ABT) CIK: 0000001800 --- Reporting Owner --- Name: Stratton John G CIK: 0001385262 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common shares without par value Date: 2026-04-24 | Code: A (Grant or award) Shares: +2,286 | Price: $0.00 Shares Owned After: 21,319 | Ownership: D (Direct) Footnotes: [F1] Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). --- Footnotes (Complete Index) --- F1: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). --- Signature --- /s/ /s/ John G. Stratton by Jessica H. Paik, Attorney-in-Fact (2026-04-28)